These companies have become household names.
Compare PFE Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Pfizer
It depends mainly on the number of breakthrough cases of COVID-19.
Here's how the two big-pharma stocks stack up against each other.
Pfizer has expanded its mRNA program into a new area.
Here are three companies for long-term investors to consider this month.
Pfizer's Cibinqo snagged an approval in Japan to treat patients with eczema.
Rare heart inflammation issues with Moderna's vaccine could work to Pfizer's advantage -- but only slightly.
Pfizer might not be far behind Merck in launching a COVID-19 pill.
Pfizer is now set to receive money from its top rival in the pneumococcal vaccine market.
The companies will vie for leadership in this billion-dollar market.